Alto Pharmacy, a digital pharmaceutical startup based in San Francisco that’s backed by SoftBank Group Corp., agreed to be ...

We think CR Pharma has a weaker financial position compared with the top three medical distributors. Similar to other pharmaceutical distributors, accounts receivable make up a large portion of its ...

Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...

Merck's revenues are driven by cancer med Keytruda, which faces patent expiry by 2028. See why I rate MRK stock a hold.

Discover Corvus Pharmaceuticals' Q4 2024 earnings insights, highlighting soquelitinib's trial progress, upcoming milestones for 2025, and robust ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

German pharmaceutical firm Stada said on Tuesday it was generally evaluating all options for its further ownership, including a possible initial public offering.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a ...

Try Now>> See the top stocks recommended by analysts >> Read More on TARS: Questions or Comments about the article? Write to [email protected] Tarsus Pharmaceuticals NewsMORE Related Stocks ...

Today, we are looking at generic pharmaceuticals stocks, starting with Amphastar Pharmaceuticals (NASDAQ:AMPH). The generic pharmaceutical industry operates on a volume-driven, low-cost business model ...

This top company remains a solid pharmaceutical stock to own long-term, offering an outstanding entry point and a massive 4.15% dividend. Bristol-Myers Squibb Co. (NYSE: BMY) discovers ...